HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of cervical myeloradiculopathy with positive serum anti-GT1a antibody].

Abstract
A 19-year-old man with cervical myeloradiculopathy is reported. He was admitted to our hospital because of acute muscle weakness of upper limbs, which developed two weeks after respiratory tract infection. Neurologic examination revealed prominent muscular weakness of upper limbs. Deep tendon reflexes showed hyporeflexia in upper limbs and hyperreflexia in lower limbs. Serum IgG anti-GT1a antibody was detected by thin-layer chromatography and immunoblotting. Neck MRI revealed T2-weighted high intensity legions and swelling in spinal cord at third to sixth cervical segment. The muscular weakness and the cervical legion in MRI improved two weeks after steroid treatment. These findings indicate the involvement of cervical pyramidal tract as well as that of cervical roots in the patient. Neurological symptoms of the present case differed from those of pharyngeal-cervical-brachial variant (PCB) of Guillain-Barré syndrome, although serum anti-GT1a antibody was positive.
AuthorsY Oshima, T Mitsui, H Yoshino, A Hirono, T Matumoto
JournalRinsho shinkeigaku = Clinical neurology (Rinsho Shinkeigaku) 2001 Apr-May Vol. 41 Issue 4-5 Pg. 184-6 ISSN: 0009-918X [Print] Japan
PMID11676159 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Autoantibodies
  • Biomarkers
  • Gangliosides
  • Immunoglobulin G
  • trisialoganglioside GT1
Topics
  • Adult
  • Autoantibodies (blood)
  • Biomarkers (blood)
  • Gangliosides (immunology)
  • Humans
  • Immunoglobulin G (blood)
  • Magnetic Resonance Imaging
  • Male
  • Polyradiculoneuropathy (diagnosis, immunology, pathology)
  • Pyramidal Tracts (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: